Novartis’ $23 Billion U.S. Investment: A Green Blueprint for Construction
In the dynamic intersection of construction and sustainability, Novartis’ recent announcement to invest $23 billion in the construction and expansion of U.S. facilities sends a clear signal to the industry. The Swiss pharmaceutical giant’s ambitious
Novartis’ $23 Billion U.S. Investment: A Green Blueprint for Construction Read More »